The Challenge
A medical technology firm faced critical delays deploying highly sensitive diagnostic equipment to several countries in the APAC region, notably Australia and Japan, each with unique and demanding regulatory approvals beyond standard customs requirements (e.g., TGA in Australia, PMDA in Japan).
